Difference between revisions of "AcoL"
Line 89: | Line 89: | ||
=Expression and regulation= | =Expression and regulation= | ||
− | |||
* '''Operon:''' ''[[acoA]]-[[acoB]]-[[acoC]]-[[acoL]]'' [http://www.ncbi.nlm.nih.gov/sites/entrez/11274109 PubMed] | * '''Operon:''' ''[[acoA]]-[[acoB]]-[[acoC]]-[[acoL]]'' [http://www.ncbi.nlm.nih.gov/sites/entrez/11274109 PubMed] | ||
* '''[[Sigma factor]]:''' [[SigL]] [http://www.ncbi.nlm.nih.gov/sites/entrez/11274109 PubMed] | * '''[[Sigma factor]]:''' [[SigL]] [http://www.ncbi.nlm.nih.gov/sites/entrez/11274109 PubMed] | ||
− | * '''Regulation:''' repressed by glucose ([[CcpA]]) | + | * '''Regulation:''' |
+ | ** repressed by glucose ([[CcpA]]) {{PubMed|10666464}} | ||
+ | ** induced by acetoin ([[AcoR]]) [http://www.ncbi.nlm.nih.gov/sites/entrez/11274109 PubMed] | ||
+ | ** induced under anaerobic conditions ([[Fnr]]) {{PubMed|16428414}} | ||
− | * '''Regulatory mechanism:''' [[CcpA]]: transcription repression | + | * '''Regulatory mechanism:''' |
+ | ** [[CcpA]]: transcription repression {{PubMed|10666464}} | ||
+ | ** [[AcoR]]: transcription activation (interaction with [[SigL]]-containing RNA polymerase) [http://www.ncbi.nlm.nih.gov/sites/entrez/11274109 PubMed] | ||
+ | ** [[Fnr]]: indirect positive regulation via [[NarG]]-[[NarH]]-[[NarJ]]-[[NarI]] {{PubMed|16428414}} | ||
− | * '''Additional information:''' | + | * '''Additional information:'''the mRNA is very stable (half-life > 15 min) [http://www.ncbi.nlm.nih.gov/sites/entrez/12884008 PubMed] |
=Biological materials = | =Biological materials = | ||
Line 122: | Line 127: | ||
=References= | =References= | ||
− | <pubmed>11274109,10368162,, | + | <pubmed>11274109,10368162,10666464,16428414 12884008 </pubmed> |
[[Category:Protein-coding genes]] | [[Category:Protein-coding genes]] |
Revision as of 18:01, 14 May 2010
- Description: acetoin dehydrogenase E3 component (dihydrolipoamide dehydrogenase)
Gene name | acoL |
Synonyms | yfjH |
Essential | no |
Product | acetoin dehydrogenase E3 component (dihydrolipoamide dehydrogenase) |
Function | acetoin utilization |
Metabolic function and regulation of this protein in SubtiPathways: Central C-metabolism | |
MW, pI | 48 kDa, 5.273 |
Gene length, protein length | 1374 bp, 458 aa |
Immediate neighbours | acoC, acoR |
Get the DNA and protein sequences (Barbe et al., 2009) | |
Genetic context This image was kindly provided by SubtiList
|
Contents
The gene
Basic information
- Locus tag: BSU08090
Phenotypes of a mutant
Database entries
- DBTBS entry: [1]
- SubtiList entry: [2]
Additional information
The protein
Basic information/ Evolution
- Catalyzed reaction/ biological activity: Protein N(6)-(dihydrolipoyl)lysine + NAD+ = protein N(6)-(lipoyl)lysine + NADH (according to Swiss-Prot)
- Protein family: class-I pyridine nucleotide-disulfide oxidoreductase family (according to Swiss-Prot)
- Paralogous protein(s):
Extended information on the protein
- Kinetic information:
- Domains:
- Modification:
- Cofactor(s):
- Effectors of protein activity:
- Interactions:
- Localization: cytoplasm (according to Swiss-Prot)
Database entries
- Structure:
- UniProt: O34324
- KEGG entry: [3]
- E.C. number: 1.8.1.4
Additional information
Expression and regulation
- Regulation:
- Regulatory mechanism:
- Additional information:the mRNA is very stable (half-life > 15 min) PubMed
Biological materials
- Mutant:
- Expression vector:
- lacZ fusion:
- GFP fusion:
- two-hybrid system:
- Antibody:
Labs working on this gene/protein
Michel Debarbouille, Pasteur Institute, Paris, France Homepage
Your additional remarks
References